Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast media (LOCM), according to new data presented at EuroPCR 2015.

Fluke Biomedical launched Advantage Training, an online center aimed at providing accessible training to the biomedical engineering community.

Elekta has CE marked the latest version (v5.10) of its popular Monaco treatment planning system, enabling its sale to European clinics. The system supports major treatment techniques including advanced 3-D planning, intensity modulated radiation therapy (IMRT), volumetric arc therapy (VMAT) and stereotactic planning – all in a single system.

Five new studies evaluating the use of imaging and urine-based biomarkers as ways to improve prostate cancer detection will be presented during the 110th annual scientific meeting of the American Urological Association (AUA). The research will be highlighted by study authors during a special press conference. Scott Eggener, M.D., AUA spokesperson and associate professor of surgery for urologic oncology at the University of Chicago Medicine, will moderate the session.

PHS Technologies Group LLC, a unit of PACSHealth LLC announced that Dell Healthcare and Life Sciences will become a marketing, distribution and hosting partner for its DoseMonitor OnLine software solution.

Dell Cloud Clnical Archive


Magnetic resonance imaging (MRI) provides important information about a woman’s future risk of developing breast cancer, according to a new study published in Radiology. Researchers said the findings support an expanded role for MRI in more personalized approaches to breast cancer screening and prevention.


Blackford Analysis announced that its Smart Localizer product will be officially launched at the Society for Imaging Informatics in Medicine (SIIM) annual meeting in Washington, D.C.

Subscribe Now